AIMS: We sought to evaluate bleeding complications and periprocedural outcomes of the radial approach (RA) as compared to the femoral approach (FA) during percutaneous coronary intervention (PCI) in "real-world" patients with ST-segment elevation myocardial infarction (STEMI). METHODS AND RESULTS: The study group consisted of 22,812 consecutive patients with STEMI treated with PCI and stent implantation between January 2014 and June 2015 in 151 tertiary invasive cardiology centres in Poland (the ORPKI Polish National Registry). Patients treated using the RA and FA were compared using a propensity score analysis to avoid possible selection bias. The analysis was carried out in an "as-treated" manner. The FA was used in 9,334 (40.9%) and the RA in 13,478 (59.1%) patients. After propensity score matching, a higher total amount of contrast (191.8±8.0 vs. 174.8±68.8 ml; p=0.001) and lower radiation doses (1,279.5±1,346.3 vs. 1,182.6±887 mGy; p=0.02) were reported in FA. More access-site-related bleeding complications after both angiography (0.17% vs. 0.02%; p=0.004) and PCI (0.23% vs. 0.09%; p=0.049) were reported in the FA group. Periprocedural death (1.94% vs. 0.93%; p=0.001) was more common after PCI performed with the FA. CONCLUSIONS: The radial approach was associated with a lower incidence of periprocedural death in STEMI patients as well as a significant reduction of bleeding complications at the access site.
AIMS: We sought to evaluate bleeding complications and periprocedural outcomes of the radial approach (RA) as compared to the femoral approach (FA) during percutaneous coronary intervention (PCI) in "real-world" patients with ST-segment elevation myocardial infarction (STEMI). METHODS AND RESULTS: The study group consisted of 22,812 consecutive patients with STEMI treated with PCI and stent implantation between January 2014 and June 2015 in 151 tertiary invasive cardiology centres in Poland (the ORPKI Polish National Registry). Patients treated using the RA and FA were compared using a propensity score analysis to avoid possible selection bias. The analysis was carried out in an "as-treated" manner. The FA was used in 9,334 (40.9%) and the RA in 13,478 (59.1%) patients. After propensity score matching, a higher total amount of contrast (191.8±8.0 vs. 174.8±68.8 ml; p=0.001) and lower radiation doses (1,279.5±1,346.3 vs. 1,182.6±887 mGy; p=0.02) were reported in FA. More access-site-related bleeding complications after both angiography (0.17% vs. 0.02%; p=0.004) and PCI (0.23% vs. 0.09%; p=0.049) were reported in the FA group. Periprocedural death (1.94% vs. 0.93%; p=0.001) was more common after PCI performed with the FA. CONCLUSIONS: The radial approach was associated with a lower incidence of periprocedural death in STEMI patients as well as a significant reduction of bleeding complications at the access site.
Authors: Rafał A Januszek; Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Jacek Legutko; Łukasz Rzeszutko; Paweł Kleczyński; Dariusz Dudek; Stanisław Bartuś Journal: Cardiol J Date: 2018-09-20 Impact factor: 2.737
Authors: Zbigniew Siudak; Kalina Wysocka-Dubielecka; Krzysztof Malinowski; Artur Dziewierz; Tomasz Tokarek; Krzysztof Plens; Dariusz Dudek Journal: Cardiol J Date: 2018-08-29 Impact factor: 2.737
Authors: Rafał A Januszek; Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Dariusz Dudek; Stanisław Bartuś Journal: Cardiol J Date: 2018-04-19 Impact factor: 2.737
Authors: Zbigniew Siudak; Marek Grygier; Wojciech Wojakowski; Krzysztof P Malinowski; Adam Witkowski; Mariusz Gąsior; Dariusz Dudek; Stanisław Bartuś Journal: Catheter Cardiovasc Interv Date: 2020-07-20 Impact factor: 2.692
Authors: Karol Sabatowski; Michał Szotek; Krzysztof Węgrzyn; Tomasz Tokarek; Zbigniew Siudak; Dariusz Dudek Journal: Postepy Kardiol Interwencyjnej Date: 2018-03-22 Impact factor: 1.426
Authors: Rafał Januszek; Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Dariusz Dudek; Stanisław Bartuś Journal: PLoS One Date: 2018-10-01 Impact factor: 3.240
Authors: Tomasz Tokarek; Artur Dziewierz; Krzysztof Plens; Tomasz Rakowski; Michał Zabojszcz; Dariusz Dudek; Zbigniew Siudak Journal: J Clin Med Date: 2019-09-18 Impact factor: 4.241
Authors: Lukasz Zandecki; Agnieszka Janion-Sadowska; Jacek Kurzawski; Lukasz Piatek; Michal Zabojszcz; Krzysztof Plens; Zbigniew Siudak; Marcin Sadowski Journal: PLoS One Date: 2020-06-16 Impact factor: 3.240
Authors: Rafał Januszek; Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Tomasz Kameczura; Tomasz Tokarek; Dariusz Dudek; Stanisław Bartuś Journal: Arch Med Sci Date: 2019-06-22 Impact factor: 3.318